Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
We read with great interest the paper by Kapsogeorgou et al published recently in The Annals of the Rheumatic Diseases focusing on the link between miR200-5bp and the risk of lymphoma in primary Sjögren syndrome (pSS).1 In this study, the authors assess the level of this miRNA within salivary gland biopsy in three groups of patients with pSS: group 1 is made of patients without lymphoma, group 2 is made of patients at high risk of lymphoma and who developed lymphoma in median 3.67 years after biopsy and the last group 3 is made of patients with lymphoma at the time of biopsy. Interestingly, the authors demonstrate that miR200b-5p is significantly decreased in patients with lymphoma and moreover in patients at high risk of lymphoma. This result strongly suggests that miR200b-5p could be considered as a new biomarker predictor of future occurrence of lymphoma in …
Competing interests None declared.
Patient consent Not required.
Provenance and peer review Not commissioned; internally peer reviewed.